Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 0.93% | $3.67M | $243.29B | 49.19% | 78 Outperform | |
| Roche Holding AG | 0.86% | $3.40M | CHF248.72B | 32.86% | 73 Outperform | |
| Novartis | 0.84% | $3.32M | $253.62B | 29.58% | 80 Outperform | |
| ASML Holding | 0.79% | $3.11M | $423.56B | 55.08% | 81 Outperform | |
| Royal Bank Of Canada | 0.75% | $2.96M | $227.62B | 28.90% | 75 Outperform | |
| Celestica | 0.69% | $2.73M | $37.41B | 242.70% | 76 Outperform | |
| Vinci SA | 0.66% | $2.61M | €67.88B | 19.17% | 76 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.66% | $2.60M | €312.22B | -0.03% | 78 Outperform | |
| Toyota Motor | 0.65% | $2.56M | $255.08B | 11.71% | 81 Outperform | |
| SAFRAN SA | 0.65% | $2.56M | €122.07B | 37.81% | 67 Neutral |